Wuppertal, Germany

Petra Bastian

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Petra Bastian: Innovator in Osteoporosis Treatment

Introduction

Petra Bastian is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of osteoporosis. Her innovative work has led to the development of a unique pharmaceutical preparation that addresses a critical need in the medical community.

Latest Patents

Petra Bastian holds a patent for her invention titled "Subcutaneous osteoporosis compositions." This invention focuses on a pharmaceutical preparation designed for subcutaneous, parenteral administration. It contains bisphosphonic acids or their salts as the active substance. The preparation allows for the administration of relatively high concentrations of bisphosphonates locally, minimizing the risk of incompatibilities.

Career Highlights

Throughout her career, Petra has demonstrated a commitment to advancing medical treatments. Her work at Hoffmann-La Roche Inc. has positioned her as a key player in the pharmaceutical industry. She has been instrumental in developing innovative solutions that improve patient outcomes.

Collaborations

Petra has collaborated with esteemed colleagues, including Rainer Bader and Achim Goepferich. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of her work.

Conclusion

Petra Bastian's contributions to the field of osteoporosis treatment exemplify her dedication to innovation in pharmaceuticals. Her patent for subcutaneous osteoporosis compositions highlights her ability to address complex medical challenges effectively. Through her work, she continues to make a significant impact on patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…